Cargando…
Rare versus common diseases: a false dichotomy in precision medicine
Precision medicine initiatives are being launched worldwide, each with the capacity to sequence many thousands to millions of human genomes. At the strategic planning level, all are debating the extent to which these resources will be directed towards rare diseases (and cancers) versus common diseas...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904920/ https://www.ncbi.nlm.nih.gov/pubmed/33627657 http://dx.doi.org/10.1038/s41525-021-00176-x |